Inhibition of Osteoclastogenesis for Periprosthetic Osteolysis Therapy Through the Suppression of P38 Signaling by Fraxetin
International Journal of Molecular Medicine - Greece
doi 10.3892/ijmm.2018.3698
Full Text
Open PDFAbstract
Available in full text
Date
May 21, 2018
Authors
Publisher
Spandidos Publications